NIGERIA’S National Agency for Food Drugs and Administration Control (Nafdac) has confirmed that it has received four different submissions from local producers claiming that have uncovered a drug which can cure the coronavirus.
Since the outbreak of the Covid-19 pandemic late last year, scientists the world over have been desperately looking for a vaccine to prevent the virus and a remedy to cure it. So far, however, no drug has completed clinical trials and been approved by any regulatory body despite several of them being touted as the ultimate remedy.
Professor Mojisola Adeyeye, Nafdac’s director-general, conformed that her agency has received four submissions from Nigerians, who claim to have found a cure to Covid-19. She said the entries followed a call for researchers and practitioners to submit potential solution to the deadly virus.
“I made a call for people to submit their application and I believe we have about three or four now and we are going to expedite the processing because it takes a while for us to go through the laboratory testing and what not but I have already given the directive to expedite. So, where we are right now is just to make sure that the information submitted is okay and by the end of the week, we may be sending these samples to the lab after we must have gone to inspect the site where the products are made because we don’t want a product that somebody will take and the person will start vomiting.
“So, we will go and inspect the site to make sure that whatever sample we are going to get must have been prepared in an environment that will not make the drug to compromise the health of the user. If somebody says he or she has a remedy for Covid-19 first of all, we want to know the history of the plant or the family the plant belongs to, background information on the botanical characteristics of the plant, we will also want to know whether the plant has been used for anything before because sometimes, we use one plant for several diseases and the usage will be different for a particular disease.
“We will also ask for any written or published document about the plant because the plant may not come from Nigeria and it may be available in other climes. So, we want to ensure that we get enough information and once that application is submitted with the information, then we will start the process and part of the process involves inspecting where the medicinal product was prepared to be sure that it is not going to compromise the health of the people,” Professor Adeyeye added.